Skip to main content
SpringerLink
Log in

Usefulness of early morning urine estrone-3-glucuronide assay in the monitoring ovarian secretory function in precocious puberty

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

To evaluate the usefulness of the urinary estrone-3-glucuronide (EI-3-G) in the monitoring of the ovarian function in girls, we studied 11 girls with idiopathic central precocious puberty (ICPP) treated with LHRH analogs (LHRHa) for 2–5 years. Plasma LH, FSH, 17 -ß-Estradiol (E2) levels, early morning urine (EMU) E1-3-G concentrations, were assessed before and 3, 6,12 months after the onset of treatment. As expected, mean basal plasma LH, FSH and E2 concentrations, as well as mean basal EMU E1-3-G levels were significantly (p<0.01) higher in patients studied than in normal, age matched, prepubertal controls. Three out of the 11 sexually advanced girls showed undetectable (<15 pg/ml) basal plasma E2 values. On the contrary, in each patient studied, individual basal EI-3-G levels were higher than in normal age-matched prepubertal girls. LHRHa treatment significantly suppressed both basal and peak stimulated plasma gonadotropins, plasma E2 and EMU E1-3-G. However, while serum E2 levels were below the assay detection limit, not allowing to assess the degree of gonadal suppression, E1-3-G urinary concentrations were detectable in each subject treated, in the range of the normal prepubertal values. EMU E1-3-G determination seems to be a very sensitive and reliable approach to the monitoring of the effectiveness of LHRHa treatment in sexually advanced girls, allowing to detect very low estrogen concentrations and to achieve the desired ovarian suppression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Grumbach M.M, Kaplan S.L. Recent advances in the diagnosis and management of sexual precocity. Acta Paediatr. Jpn 30 (Suppl): 155, 1988.

    Article  PubMed  Google Scholar 

  2. Comite F., Cutler G.B. Jr., Rivier J., Vale W.W., Loriaux D.L., Cowley W.F. Jr. Short term treatment of idiopathic precocious puberty with a long acting analogue of luteinizing hormone-releasing hormone: a preliminary report. N. Engl. J. Med. 305: 1546, 1981.

    Article  PubMed  CAS  Google Scholar 

  3. Boepple P.A., Mansfield M.J., Wierman M., Rudlin C.R., Bode H.H., Crigler J.F. Jr., Crowford J.D., Crowley W.F. Jr. Use of a potent long acting agonist of gonadotropin-releasing hormone in the treatment of precociuous puberty. Endocr. Rev. 7: 24, 1986.

    Article  PubMed  CAS  Google Scholar 

  4. Kaplan S.L., Grumbach M.M. True precocious puberty; treatment with GnRH-agonists. In: Delmane van de Wall H.A. (Ed.), Control of the onset of puberty III. Elvieser Science Publishers BV Amsterdam: 1989 p. 357.

    Google Scholar 

  5. Mansfield M.J., Beardsworth D.E., Loughlin J.S., Crawford J.D., Bode H.H., Rivier J., Valew Kushner D.C., Krigler J.F., Crowley W.F. Jr. Long term treatment of central precocious puberty with a long acting analogue of luteinizing hormone-releasing hormone. N. Engl. J. Med. 309: 1286, 1983.

    Article  PubMed  CAS  Google Scholar 

  6. Styne D.M., Harris D.A., Egli C.A., Conte F.A., Kaplan S.L., Rivier J., Vale W., Grumbach M.M. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography and the hypothalamic-pituitary-gonadal axis. J. Clin. Endocrinol. Metab. 61: 142, 1985.

    Article  PubMed  CAS  Google Scholar 

  7. Comite F., Cassarola F., Barnes K.M., Hench K.D., Dwyer A., Skerda M.C., Loriaux D.L., Cutler J.B. Jr., Pesovitz O.H. Luteinizing hormone releasing hormone analogue therapy for central precocous puberty: long term effect on somatic growth, bone maturation and height prediction. JAMA 255: 2613, 1986.

    Article  PubMed  CAS  Google Scholar 

  8. Manasco P.K., Peskovitz O.H., Feuillan P.P., Hench K.D., Barnes K.M., Jones J., Hill S.C., Loriaux D.L., Cutler G.B. Resumption of puberty after long term luteinizing hormone releasing hormone agonist treatment of central precocious puberty. J. Clin. Endocrinol. Metab. 67: 368, 1988.

    Article  PubMed  CAS  Google Scholar 

  9. Oerter K.E., Manasco P.K., Barnes K.M., Jones J., Hill S., Cutler G.B. Jr. Adult height in precocious puberty after long-term treatmernt with Deslorelin. J. Clin. Endocrinol. Metab. 73: 1235, 1991.

    Article  PubMed  CAS  Google Scholar 

  10. Collins W.P., Collins P.O., Kilpatrick M.J., Manning P.A., Pike J.M., Tyler J.P.P. The concentrations of urinary oestrone 3 glucuronidc, LH and Pregnanediol 3 alfa glucuronide as indices of ovarian function. Acta Endocrinol. (Copenh.) 90: 336, 1979.

    CAS  Google Scholar 

  11. Metcalf M.G., Hunt E.G. Calculation of estrogen excretion rates from urinary estrogen to creatinine ratios. Clin. Biochem. 92: 75, 1976.

    Article  Google Scholar 

  12. Baker S.T., Jennison K.M., Kellie A.E. The direct radioimmunoassay of estrogen glucuronides in human female urine. Biochem. J. 177: 729, 1979.

    PubMed Central  PubMed  CAS  Google Scholar 

  13. Collins W.P., Branch C.M., Collins P.O. Biochemical indices of the fertile period in women. Int. J. Fertil. 26: 196, 1981.

    PubMed  CAS  Google Scholar 

  14. WHO Task Force on Methods for the Determination of the Fertile Period. The measurement of urinary steroid glucuronides as indices of the fertile period in women. J. Steroid Biochem. 17: 695, 1982.

    Article  Google Scholar 

  15. Lehtinen T., Aldercreutz H. Solid phase radioimmunoassays of estriol-16-alfa-glucuronide in urine and pregnancy plasma. J. Steroid Biochem. 8: 99, 1977.

    Article  PubMed  CAS  Google Scholar 

  16. Lonning P.E., Skulstad P., Sunde A., Thorsen T. Separation of urinary metabolites of radiolabelled estrogens in man by HPLC. J. Steroid Biochem. 32: 91, 1989.

    Article  PubMed  CAS  Google Scholar 

  17. Collins W.P., Newton J.R. In: Curry A.S., Hewitt J.V., (Eds.) Biochemistry of women: clinical concepts. CRC Press. Cleveland Ohio, 1974, p. 1.

  18. Pazzagli M., Magini A., Forti G., Bolelli G., Scarselli G., Noci I., Pellegrini S., Rodbard D., Serio M. Measurement of glucuronometabolites of 17 beta estradiol and progesterone in diluted overnight urine. An approach to the study of luteal insufficiency. J. Steroid Biochem. 27: 399, 1987.

    Article  PubMed  CAS  Google Scholar 

  19. Magini A., Pazzagli M., Salerno R., Simonis M., Mustacchi G., Serio M. Ovarian function in premenopausal women affected by breast cancer: the measurement of glucurono-conjugate metabolites of 17 beta estradiol and progesterone throughout one entire menstrual cycle. J. Steroid Biochem. 36(6): 523, 1990.

    Article  PubMed  CAS  Google Scholar 

  20. Bruni V., Dei M., Deligeoroglou E., Innocenti P., Pandimiglio A.M., Magini A., Bassi F. Breast development in adolescent girls. Adolesc. Pediatr. Gynaecol. 3: 201, 1990.

    Article  Google Scholar 

  21. Tanner J.M., Whitehouse R.H., Takaishi M. Standards from birth to maturity for heigth, weight, height velocity: British children. Parts I and II. Arch. Dis. Child. 47: 454; 1965.

    Google Scholar 

  22. Tanner J.M., Withehouse R.H., Cameron N., Marshall W.A., Healy M.J.R., Goldstein H. Assessment of skeletal maturity and prediction of adult height (TW2 Method) ed. 2. Accademic Press, New York, 1983.

    Google Scholar 

  23. Hattori N., Shimatzu A., Yamanaha C., Momoi T., Imura H. Nocturnal urinary growth hormone excretion in children with short stature. Acta Endocrinol. (Copenh.) 119: 113, 1988.

    CAS  Google Scholar 

  24. Werder E.A., Murset G., Zachmann M., Brook C.D.G. Treatment of precocious puberty with cyproterone acetate. Pediatr. Res. 8: 248, 1974.

    Article  PubMed  CAS  Google Scholar 

  25. Lee P.A. Medroxyprogesterone therapy for sexual precocity in girls. Am. J. Child Dis. 135: 443, 1981.

    CAS  Google Scholar 

  26. Sorgo W., Kyraly E., Homoki J. The effect of cyproterone acetate on statural growth in children with precocious puberty. Acta Endocrinol. (Copenh.) 115: 44, 1987.

    CAS  Google Scholar 

  27. Boepple P.A., Mansfield M.J., Crawford J.D., Crigler J.F. Jr., Blizzard R.M., Crowley W.F. Jr. Final heights in girls with central precocious puberty (CPP) following GnRH agonist (GnRHa) induced pituitary-gonadal suppression. Pediatr. Res. 29: 74 A (Abst), 1991.

    Google Scholar 

  28. Manasco P.K., Pescovitz O.H., Feuillan P.P. Resumption of puberty after long term luteinizing hormone realising hormone agonist treatment of central precocious puberty. J. Clin. Endocrinol. Metab. 67: 368, 1988.

    Article  PubMed  CAS  Google Scholar 

  29. Hall D.A., Crowley W.F. Jr., Wierman M.E., Simeone J.F., McCarthy K.A. Sonographic monitoring of LHRH analogue therapy in idiopathic precocious puberty in young girls. J. Clin. Ultrasound 14: 331, 1986.

    Article  PubMed  CAS  Google Scholar 

  30. Boepple P.A., Mansfield M.J., Landy H., Crowley W.F. Jr. Gn-Rh agonist therapy of Central Precocious Puberty. In: Grave G.D., Cutler G.B. (Eds.), Sexual Precocity: Etiology Diagnosis and Management. Raven Press, New York, 1993, p. 11.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Fisiopatologia Ciinica, Unità di Endocrinologia, Viale Pieraccini 18, 50134, Firenze

    Francesca Bassi, O. Bartolini, A. S. Neri, R. G. Gheri & A. Magini

  2. Clinica Ostretica e Ginecologia I, Università di Firenze, Firenze, Italy

    S. Bucciantini & V. Bruni

Authors
  1. Francesca Bassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Bartolini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. S. Neri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. G. Gheri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Magini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Bucciantini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. V. Bruni
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bassi, F., Bartolini, O., Neri, A.S. et al. Usefulness of early morning urine estrone-3-glucuronide assay in the monitoring ovarian secretory function in precocious puberty. J Endocrinol Invest 18, 98–103 (1995). https://doi.org/10.1007/BF03349708

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349708

Key-words

Search

Navigation